| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.86B | 15.13B | 12.93B | 12.84B | 12.36B | 11.09B |
| Gross Profit | 3.19B | 3.23B | 3.26B | 3.05B | 2.36B | 1.82B |
| EBITDA | 1.93B | 2.23B | 1.93B | 1.56B | 1.18B | 1.27B |
| Net Income | 708.00M | 896.00M | 776.00M | 556.00M | 248.00M | 288.00M |
Balance Sheet | ||||||
| Total Assets | 27.35B | 27.29B | 24.75B | 22.35B | 21.38B | 21.25B |
| Cash, Cash Equivalents and Short-Term Investments | 1.05B | 973.00M | 588.00M | 1.14B | 1.86B | 1.26B |
| Total Debt | 9.06B | 8.51B | 6.87B | 5.58B | 5.54B | 6.10B |
| Total Liabilities | 14.31B | 14.18B | 12.31B | 10.87B | 10.38B | 10.30B |
| Stockholders Equity | 13.03B | 13.11B | 12.43B | 11.48B | 11.00B | 10.95B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.20B | -1.37B | -490.00M | 1.40B | -208.00M |
| Operating Cash Flow | 0.00 | 2.14B | 388.00M | 668.00M | 1.79B | 352.00M |
| Investing Cash Flow | 0.00 | -3.25B | -1.89B | -1.24B | -442.00M | -648.00M |
| Financing Cash Flow | 0.00 | 1.50B | 948.00M | -158.00M | -772.00M | 106.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥14.09B | 8.02 | ― | 3.89% | -1.35% | -3.51% | |
77 Outperform | ¥7.13B | 0.81 | ― | 1.96% | 4.17% | 179.30% | |
74 Outperform | ¥196.73B | 8.69 | ― | 4.09% | -1.41% | -13.30% | |
72 Outperform | ¥13.62B | 9.40 | ― | 1.81% | 3.10% | ― | |
71 Outperform | ¥119.77B | 17.82 | ― | 0.67% | 5.45% | -7.61% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
50 Neutral | ¥7.62B | 23.47 | ― | 2.97% | 3.10% | -24.84% |